INHIBITEX, INC.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 16, 2012
- Entered a material agreement · Other material eventJan 10, 2012
- Other material eventNov 29, 2011
- Results of operationsNov 4, 2011
- Director / officer changeOct 5, 2011
- Other material eventSep 21, 2011
- Other material eventAug 18, 2011
- Results of operationsAug 8, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15Feb 27, 2012
- EFFECTFeb 16, 2012
- EFFECTFeb 16, 2012
- EFFECTFeb 16, 2012
- EFFECTFeb 16, 2012
- 8-KFORM 8-KFeb 16, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4Feb 15, 2012
- 4FORM 4 SUBMISSIONFeb 15, 2012
- 4FORM 4 SUBMISSIONFeb 15, 2012
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.